| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2021―Mar―11 |
COVID-19 infection causes a reduction in neutrophil counts in patients taking clozapine |
Siobhan Gee, David Taylor |
| 2 |
[GO] |
2021―Mar―05 |
Elevated clozapine levels and toxic effects after SARS-CoV-2 vaccination |
Deborah Thompson, Clay M. Delorme, Randall F. White, William G. Honer |
| 3 |
[GO] |
2020―Jun―26 |
Clozapine and COVID-19 |
Gary Remington, Valerie Powell |
| 4 |
[GO] |
2020―Jun―26 |
Adapting to the impact of COVID-19 on mental health: an international perspective |
Rejish K. Thomas, Raheem Suleman, Marnie Mackay, Lovneet Hayer, Mohit Singh, Christoph U. Correll, Serdar Dursun |
| 5 |
[GO] |
2020―Jun―26 |
Clozapine and COVID-19: The authors respond |
Dan Siskind, William G. Honer, Scott Clark, Christoph U. Correll, Alkomiet Hasan, Oliver Howes, et al. (+12) John M. Kane, Deanna L. Kelly, Robert Laitman, Jimmy Lee, James H. MacCabe, Nick Myles, Jimmi Nielsen, Peter F. Schulte, David Taylor, Helene Verdoux, Amanda Wheeler, Oliver Freudenreich |
| 6 |
[GO] |
2020―Apr―28 |
Consensus statement on the use of clozapine during the COVID-19 pandemic |
Dan Siskind, William G. Honer, Scott Clark, Christoph U. Correll, Alkomiet Hasan, Oliver Howes, et al. (+12) John M. Kane, Deanna L. Kelly, Robert Laitman, Jimmy Lee, James H. MacCabe, Nick Myles, Jimmi Nielsen, Peter F. Schulte, David Taylor, Helene Verdoux, Amanda Wheeler, Oliver Freudenreich |
|
